BML Investment Partners Amends Atea Pharma Stake, Forms Group

TL;DR

**BML Investment Partners updated their Atea Pharma stake, indicating a group investment.**

AI Summary

BML Investment Partners, L.P. filed an amended Schedule 13G/A on February 7, 2024, disclosing its ownership of Atea Pharmaceuticals, Inc. common stock as of December 31, 2023. This filing indicates that BML Investment Partners, L.P. is acting as a group, suggesting a coordinated investment strategy. This matters to investors because it reveals a significant institutional holder's updated position, which can influence market perception and potentially signal confidence or concern in Atea Pharmaceuticals' future.

Why It Matters

This filing shows an institutional investor's updated stake in Atea Pharmaceuticals, Inc., which can signal their ongoing conviction or change in strategy regarding the company.

Risk Assessment

Risk Level: low — This is a routine amendment to an ownership disclosure, not indicating any immediate negative or positive event for the company.

Analyst Insight

Investors should note that BML Investment Partners, L.P. is acting as part of a group, which could imply a more coordinated and potentially influential stance on Atea Pharmaceuticals. Further investigation into the group's intentions might be warranted.

Key Players & Entities

• BML Investment Partners, L.P. (company) — the reporting person filing the SC 13G/A
• Atea Pharmaceuticals, Inc. (company) — the subject company whose securities are being reported
• Delaware (company) — place of organization for BML Investment Partners, L.P.
• December 31, 2023 (date) — date of event requiring the filing
• February 7, 2024 (date) — date the SC 13G/A was filed

FAQ

Key Financial Figures

• $0.001 — of Securities) Common Stock, par value $0.001 (CUSIP Number) 04683R106 December

Filing Documents

• avir13g.htm (SC 13G/A) — 80KB
• 0001616824-24-000017.txt ( ) — 82KB

(a)

Item 1(a). Name of Issuer: Atea Pharmaceuticals, Inc

(b)

Item 1(b). Address of Issuer's Principal Executive Offices: 225 Franklin Street, Suite 2100, Boston, MA 02110

(a)

Item 2(a). Name of Person Filing: BML Investment Partners, L.P.

(b)

Item 2(b). Address of Principal Business Office or, if none, Residence: 65 E Cedar, Suite 2 Zionsville, IN 46077

(c)

Item 2(c). Citizenship: Delaware

(d)

Item 2(d). Title of Class of Securities: Common stock, par value $0.001 per share

(e)

Item 2(e). CUSIP Number: 04683R106 Item 3. If This Statement Is Filed Pursuant to Sections 240.13d-1(b) or 240.13d-2(b) or (c), Check Whether the Person Filing Is a(n): (a) Broker or dealer registered under Section 15 of the Act (15 U.S.C. 78o); (b) Bank as defined in Section 3(a)(6) of the Act (15 U.S.C. 78c); (c) Insurance company as defined in Section 3(a)(19) of the Act (15 U.S.C. 78c); (d) Investment company registered under Section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8); (e) Investment adviser in accordance with Section 240.13d-1(b)(1)(ii)(E); (f) Employee benefit plan or endowment fund in accordance with Section 240.13d-1(b)(1)(ii)(F); (g) Parent holding company or control person in accordance with Section 240.13d-1(b)(1)(ii)(G); (h) Savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813); (i) Church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3); (j) A non-U.S. institution in accordance with Section 240.13d-1(b)(1)(ii)(J); (k) Group, in accordance with Section 240.13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with Section 240.13d-1(b)(1)(ii)(J), please specify the type of institution: ____________________________ . Item 4. (a) Amount beneficially owned: 5,602,079 (b) Percent of class: 6.5 (c) Number of shares as to which the person has: (i) Sole power to vote or to direct the vote: 140,000 (ii) Shared power to vote or to direct the vote: 5,462,079 (iii) Sole power to dispose or to direct the disposition of: 140,000 (iv) Shared power to dispose or to direct the disposition of: 5,462,079 Item 5. If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent

View Full Filing

View this SC 13G/A filing on SEC EDGAR